References
- Cancer Statistics. National Cancer Institute. 2016. [cited 2016 Mar 14]. Available from: http://www.cancer.gov/about-cancer/understanding/statistics
- Horne SD, Pollick SA, Heng HH. Evolutionary mechanism unifies the hallmarks of cancer. Int J Cancer. 2015;136(9):2012–2021.
- Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883–892.
- Ganti S, Weiss RH. Urine metabolomics for kidney cancer detection and biomarker discovery. Urol Oncol. 2011;29:551–557.
- Wettersten HI, Hakimi AA, Morin D, et al. Grade-dependent metabolic reprogramming in kidney cancer revealed by combined proteomics and metabolomics analysis. Cancer Res. 2015;75(12):2541–2552.
- DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5):e1600200.
- Bartella L, Thakur SB, Morris EA, et al. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Radiology. 2007;245(1):80–87.
- Kline EE, Treat EG, Averna TA, et al. Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection. J Urol. 2006;176(5):2274–2279.
- Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging – clinicopathologic study. Radiology. 1999;213(2):473–480.
- Wang H, Tso V, Wong C, et al. Development and validation of a highly sensitive urine-based test to identify patients with colonic adenomatous polyps. Clin Transl Gastroenterol. 2014;5(3):e54.
- Urine-based diagnostic test spots precursor to colorectal cancer. Atlantic Diagnostic Laboratories, LLC. 2016. [cited 2016 Jul 10]. Available from: https://www.mdtmag.com/news/2016/06/urine-based-diagnostic-test-spots-precursor-colorectal-cancer.
- Spratlin JL, Serkova NJ, Eckhardt SG. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res. 2009;15(2):431–440.
- Gu H, Nagana Gowda GA, Raftery D. Metabolic profiling: are we en route to better diagnostic tests for cancer? Future Oncol. 2012;8(10):1207–1210.
- Beger RD. A review of applications of metabolomics in cancer. Metabolites. 2013;3:552–574.